Abstract: The present invention relates to the use of hydrazone compounds and copper for controlling the growth of fungi.

Abstract: The present invention relates to the use of hydrazone compounds and copper for controlling the growth of fungi.

Abstract: A structure and method of fabricating the structure. The structure including: a dielectric isolation in a semiconductor substrate, the dielectric isolation extending in a direction perpendicular to a top surface of the substrate into the substrate a first distance, the dielectric isolation surrounding a first region and a second region of the substrate, a top surface of the dielectric isolation coplanar with the top surface of the substrate; a dielectric region in the second region of the substrate; the dielectric region extending in the perpendicular direction into the substrate a second distance, the first distance greater than the second distance; and a first device in the first region and a second device in the second region, the first device different from the second device, the dielectric region isolating a first element of the second device from a second element of the second device.

Abstract: A semiconductor structure operation method. The method includes providing a semiconductor structure. The semiconductor structure includes first, second, third, and fourth doped semiconductor regions. The second doped semiconductor region is in direct physical contact with the first and third doped semiconductor regions. The fourth doped semiconductor region is in direct physical contact with the third doped semiconductor region. The first and second doped semiconductor regions are doped with a first doping polarity. The third and fourth doped semiconductor regions are doped with a second doping polarity. The method further includes (i) electrically coupling the first and fourth doped semiconductor regions to a first node and a second node of the semiconductor structure, respectively, and (ii) electrically charging the first and second nodes to first and second electric potentials, respectively. The first electric potential is different from the second electric potential.

Abstract: The present invention relates to the use of hydrazone compounds and copper for controlling the growth of fungi.

Abstract: The invention provides compounds of the formula (I): and salts, tautomers, solvates and N-oxides thereof; wherein Q is CH or N; X is N, N+—O? or CR3; Y is N, N+—O? or CR3a; R1 and R2 are independently selected from hydrogen and various substituents as defined in the claims; or R1 and R2 together with the atoms to which they are attached, link to form an optionally substituted carbocyclic or heterocyclic aromatic or non-aromatic ring of 4 to 7 members; R3 is selected from hydrogen and various substituents; and R3a is selected from hydrogen and various substituents as defined in the claims. Also provided are pharmaceutical compositions containing the compounds of formula (I), processes for making the compounds and the medical uses of the compounds. The compounds of formula (I) have activity as inhibitors of CDK kinases and are useful in the treatment of inter alia proliferative diseases such as cancers.

Abstract: A semiconductor structure and associated method of formation. The semiconductor structure includes a semiconductor substrate, a first doped transistor region of a first transistor and a first doped Source/Drain portion of a second transistor on the semiconductor substrate, a second gate dielectric layer and a second gate electrode region of the second transistor on the semiconductor substrate, a first gate dielectric layer and a first gate electrode region of the first transistor on the semiconductor substrate, and a second doped transistor region of the first transistor and a second doped Source/Drain portion of the second transistor on the semiconductor substrate. The first and second gate dielectric layers are sandwiched between and electrically insulate the semiconductor substrate from the first and second gate electrode regions, respectively. The first and second gate electrode regions are totally above and totally below, respectively, the top substrate surface.

Abstract: The present invention relates to the use of mixtures containing 2-hydroxyphenylaldehyde and 2-hydroxyphenylketone heterocycloylhydrazone compounds and copper for controlling the growth of fungi and algae.

Abstract: An isolated epitaxial modulation device comprises a substrate; a barrier structure formed on the substrate; an isolated epitaxial region formed above the substrate and electrically isolated from the substrate by the barrier structure; a semiconductor device, the semiconductor device located in the isolated epitaxial region; and a modulation network formed on the substrate and electrically coupled to the semiconductor device. The device also comprises a bond pad and a ground pad. The isolated epitaxial region is electrically coupled to at least one of the bond pad and the ground pad. The semiconductor device and the epitaxial modulation network are configured to modulate an input voltage.

Abstract: A semiconductor structure. The semiconductor structure includes a semiconductor substrate, a first transistor on the semiconductor substrate, and a guard ring on the semiconductor substrate. The semiconductor substrate includes a top substrate surface which defines a reference direction perpendicular to the top substrate surface. The guard ring includes a semiconductor material doped with a doping polarity. A first doping profile of a first doped transistor region of the first transistor in the reference direction and a second doping profile of a first doped guard-ring region of the guard ring in the reference direction are essentially a same doping profile. The guard ring forms a closed loop around the first transistor.

Abstract: The invention provides a compound of the formula (I): or a salt, solvate, tautomer or N-oxide thereof, wherein M is selected from a group D1 and a group D2: and R?, E, A and X are as defined in the claims. Also provided are pharmaceutical compositions containing the compounds, processes for making the compounds and the use of the compounds in the prophylaxis or treatment of a disease state mediated by a CDK kinase, GSK-3 kinase or Aurora kinase.

Abstract: A structure for dissipating charge during fabrication of an integrated circuit. The structure includes: a substrate contact in a semiconductor substrate; one or more wiring levels over the substrate; one or more electrically conductive charge dissipation structures extending from a top surface of an uppermost wiring level of the one or more wiring levels through each lower wiring level of the one or more wiring levels to and in electrical contact with the substrate contact; and circuit structures in the substrate and in the one or more wiring layers, the charge dissipation structures not electrically contacting any the circuit structures in any of the one or more wiring levels, the one or more charge dissipation structures dispersed between the circuit structures.

Abstract: The present invention relates to the use of hydrazone compounds and copper for controlling the growth of fungi.

Abstract: The present invention relates to the use of hydrazone compounds and copper for controlling the growth of fungi.

Abstract: The present invention relates to the use of mixtures containing hydrazone compounds and copper for controlling the growth of fungi.

Abstract: The present invention relates to the use of hydrazone compounds and copper for controlling the growth of fungi.

Abstract: A method, including; simultaneously forming a first doped region of an electrostatic discharge protection device and a second doped region of a high-power device by performing a first ion implantation into a semiconductor substrate; and simultaneously forming a third doped region of the electrostatic discharge protection device and a fourth doped region of a first low power device by performing a second ion implantation into the semiconductor substrate, the first ion implantation different from the second ion implantation, the electrostatic discharge device being a different device type from the high-power device and the electrostatic discharge device having a different structure from the high-power device.

Abstract: Methods and arrangements to analyze web traffic of a portal are contemplated. Embodiments include transformations, code, state machines or other logic to analyze web traffic of a portal by a portlet receiving a request for web page content from the portal and generating a fragment of a web page. The fragment may include code to collect data from clients on web traffic of the portlet and to transmit the data to a facility for the collection of data on web traffic of the portal and the portlet. Some embodiments may involve a portal requesting web page content from a portlet, and the portal receiving a fragment of a web page from the portlet. The fragment may include code to collect data from clients on web traffic of the portlet and to transmit the data to the data collection facility.

Abstract: The present invention provides MDM2 inhibitor compounds of Formula I, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.

Abstract: The invention provides compounds of the formula (I): The compounds have activity against cyclin dependent kinases, glycogen synthase kinase and Aurora kinases and are therefore useful to treat cancer and viral diseases.